RUCAPARIB CAMSYLATE vs RUFINAMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RUCAPARIB CAMSYLATE vs RUFINAMIDE: Safety Overview
| Metric | RUCAPARIB CAMSYLATE | RUFINAMIDE |
|---|---|---|
| Total FAERS Reports | 8,240 | 871 |
| Deaths Reported | 448 | 27 |
| Death Rate | 5.4% | 3.1% |
| Hospitalizations | 1,148 | 229 |
| Average Patient Age | 65.1 yrs | 16.9 yrs |
| % Female Patients | 95.2% | 50.2% |
| FDA Approval Date | Dec 19, 2016 | Apr 15, 2025 |
| Manufacturer | pharmaand GmbH | Aurobindo Pharma Limited |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |